BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 16020533)

  • 1. Amyloid ion channels: a common structural link for protein-misfolding disease.
    Quist A; Doudevski I; Lin H; Azimova R; Ng D; Frangione B; Kagan B; Ghiso J; Lal R
    Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10427-32. PubMed ID: 16020533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.
    Lin H; Bhatia R; Lal R
    FASEB J; 2001 Nov; 15(13):2433-44. PubMed ID: 11689468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein aggregation and deposition: implications for ion channel formation and membrane damage.
    Kourie JI; Henry CL
    Croat Med J; 2001 Aug; 42(4):359-74. PubMed ID: 11471187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm.
    Lal R; Lin H; Quist AP
    Biochim Biophys Acta; 2007 Aug; 1768(8):1966-75. PubMed ID: 17553456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.
    Kvam E; Nannenga BL; Wang MS; Jia Z; Sierks MR; Messer A
    PLoS One; 2009 May; 4(5):e5727. PubMed ID: 19492089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous amyloid-formed ion channels as a common cytotoxic mechanism: implications for therapeutic strategies against amyloidosis.
    Kourie JI; Culverson AL; Farrelly PV; Henry CL; Laohachai KN
    Cell Biochem Biophys; 2002; 36(2-3):191-207. PubMed ID: 12139405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K3 fragment of amyloidogenic beta(2)-microglobulin forms ion channels: implication for dialysis related amyloidosis.
    Mustata M; Capone R; Jang H; Arce FT; Ramachandran S; Lal R; Nussinov R
    J Am Chem Soc; 2009 Oct; 131(41):14938-45. PubMed ID: 19824733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia.
    Srinivasan R; Jones EM; Liu K; Ghiso J; Marchant RE; Zagorski MG
    J Mol Biol; 2003 Nov; 333(5):1003-23. PubMed ID: 14583196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for conditions to form stable protein oligomers with amyloid-like characteristics: The unexplored basic pH.
    Ahmad B; Winkelmann J; Tiribilli B; Chiti F
    Biochim Biophys Acta; 2010 Jan; 1804(1):223-34. PubMed ID: 19836473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein interactions and misfolding analyzed by AFM force spectroscopy.
    McAllister C; Karymov MA; Kawano Y; Lushnikov AY; Mikheikin A; Uversky VN; Lyubchenko YL
    J Mol Biol; 2005 Dec; 354(5):1028-42. PubMed ID: 16290901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Process, Outcomes and Possible Elimination of Aggregation with Special Reference to Heme Proteins; Likely Remediations of Proteinopathies.
    Furkan M; Khan RH
    Curr Protein Pept Sci; 2020; 21(6):573-583. PubMed ID: 32013844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurodegenerative conformational disease and its molecular bases].
    Li WW; Cai DF; Ren HM
    Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Oligomeric and Fibrillar Species in Amyloidosis: Insights into Pathophysiology and Treatment.
    Koike H; Iguchi Y; Sahashi K; Katsuno M
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change and stabilization of the amyloid-beta(1-40) secondary structure by fluorocompounds.
    Vieira EP; Hermel H; Möhwald H
    Biochim Biophys Acta; 2003 Jan; 1645(1):6-14. PubMed ID: 12535605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.
    Moreno-Gonzalez I; Soto C
    Semin Cell Dev Biol; 2011 Jul; 22(5):482-7. PubMed ID: 21571086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
    Jaikaran ET; Clark A
    Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Cholesterol and Phospholipids in Amylin Misfolding, Aggregation and Etiology of Islet Amyloidosis.
    Singh S; Trikha S; Bhowmick DC; Sarkar AA; Jeremic AM
    Adv Exp Med Biol; 2015; 855():95-116. PubMed ID: 26149927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA; Harper JD; Lansbury PT
    Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.